SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

Shree Ganesh Biotech (India) L

BSE: 539470 01 Oct 2025
Healthcare
₹ 0.76
Shree Ganesh Biotech (India) Limited specializes in Biotechnology within the Healthcare sector.

Shree Ganesh Biotech (India) L - Share Price & Details

Market Cap
₹29.9
High /Low
1.25 / 0.74
Stock P/E
63.6
Book Value
₹1.59
Dividend Yield
0.0
ROCE
0.62
ROE
₹0.44
Face Value
1.0
PEG Ratio
-1.22
EVEBITDA
₹63.6
Debt
0.00
CMP / FCF
8.55
Debt to equity
₹0.0
NP Ann
0.28
High price all time
24.7
Piotroski score
₹4.0
Graham Number
0.65
No. Eq. Shares
39.9
Net CF
₹-0.41
Net profit
0.47
Price to book value
0.47
Interest Coverage
₹NA
Low price all time
0.7
Industry PE
61.6
Reserves
₹23.4
Free Cash Flow
₹-10.2

Broker Recommendations

No broker recommendations available

We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.


Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.0984.8
Triochem Products Ltd.,NANANANA0
Shree Ganesh Biotech (India) LNANANANA29.963.6
DESH RAKSHAK AUSHDHALAYA LTD.NANANANA27.838.1
Vineet Laboratories Limited74.6-8.6674.42027.7

Peer Comparison Chart


About Shree Ganesh Biotech (India) L

Shree Ganesh Biotech (India) Limited, with Security Code 539470, is a leading player in the Biotechnology industry, categorized under the Healthcare sector, offering Equity instruments.


Order Book


Latest News

Shree Ganesh Biotech Faces Continued Decline Amid Broader Market Gains

(06 Sep 2025)
Shree Ganesh Biotech India has reached a new 52-week low, continuing a downward trend with significant underperformance in the Pharmaceuticals...
Read more →

Shree Ganesh Biotech Faces Financial Struggles Amid Declining Stock Performance

(25 Aug 2025)
Shree Ganesh Biotech India, a microcap in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low, continuing a downward trend.
Read more →

Shree Ganesh Biotech Hits New Low Amid Broader Market Caution and Sector Trends

(11 Aug 2025)
Shree Ganesh Biotech India, a microcap in the Pharmaceuticals & Biotechnology sector, reached a new 52-week low today, reflecting a year-to-date decline.
Read more →

Shree Ganesh Biotech Faces Financial Struggles Amid Significant Stock Decline

(30 Jul 2025)
Shree Ganesh Biotech India, a microcap in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low, reflecting a...
Read more →

ShreeGanesh Bio Standalone June 2025 Net Sales at Rs 1.38 crore, down 61.09% Y-o-Y

(30 Jul 2025)
Net Sales at Rs 1.38 crore in June 2025 down 61.09% from Rs. 3.56 crore in June 2024. Story continues below Advertisement.
Read more →

Shree Ganesh Biotech Hits 52-Week Low Amid Broader Market Decline and Financial Struggles

(26 Jul 2025)
Shree Ganesh Biotech India, a microcap in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low, significantly underperforming the...
Read more →